No Data
No Data
Guoke Hengtai (301370.SZ) plans to increase its capital to Guizhou Guoke subsidiary by 9.9 million yuan.
Guoke Hengtai (301370.SZ) has issued an announcement to meet the needs of its wholly-owned subsidiary, Guizhou Guoke Hengtai Medical Technology Co., Ltd...
Guoke Hengtai: 2024 Semi-Annual Report
Guoke Hengtai: 2024 Semi-Annual Report Summary
Guoke Hengtai (301370.SZ) released its performance for the first half of the year, with a net income of 62.9189 million yuan, a decrease of 4.56%.
Guoke Hengtai (301370.SZ) released its 2024 interim report. During the reporting period, the company achieved revenue...
Guoke Hengtai (301370.SZ): The net income in the first half of the year was 62.9189 million yuan, a year-on-year decrease of 4.56%.
国科恒泰 (301370.SZ) released its semi-annual report for 2024, with operating revenue of 3.659 billion yuan, a year-on-year decrease of 5.59%; net income attributable to shareholders of listed companies of 62.9189 million yuan, a year-on-year decrease of 4.56%; net income attributable to shareholders of listed companies after deduction of non-recurring gains and losses of 62.6816 million yuan, a year-on-year decrease of 4.68%; basic earnings per share of 0.13 yuan.
Guoke Hengtai (301370.SZ): Its wholly-owned subsidiary has been identified as a "specialized, special and new" small and medium-sized enterprise in Peking.
On August 27, Gelonghui | Guokexinxing (301370.SZ) announced that its wholly-owned subsidiary Guokexing (Beijing) Medical Technology Co., Ltd. (hereinafter referred to as Guokexing) recently received the "Specialized, Special and New" Small and Medium-sized Enterprise Certificate of Beijing (Certificate Number: 2024ZJTX0798) issued by the Beijing Economic and Information Bureau, valid from August 2024 to August 2027.
No Data
No Data